[1] Cidon EU. Systemic treatment of hepatocellular carcinoma: Past, present and future. World J Hepatol, 2017,9:797-807.
[2] Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin,2005,55:74-108.
[3] Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010, 17: 1471-1474.
[4] Imamura H,Matsuyama Y,Tanaka E,et al.Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol,2003,38:200-207.
[5] Coppola N, de Stefano G, Panella M, et al. Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.Oncotarget,2017,8:25289-25299.
[6] Zhu PP, Yuan SG, Liao Y, et al. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma. World J Gastroenterol,2015,21:7254-7263.
[7] Zhou Y,Lǚ X,Li S, et al. Correlation between the overexpression of urokinase receptor isoform uPAR (D1D2) and hepatic cell malignant transformation. Mol med rep,2014,9:1689-1696.
[8] Al-Zoubi S, Wassouf A, Zetoune AB. Measuring levels of osteopontin as potential biomarker for hepatocellular carcinoma in Syrian patients. Gastroenterol Hepatol Bed Bench,2017,10:97-101.
[9] 朱求实, 冯贤松.肝癌复发的分子标记物研究现状. 中华外科杂志, 2006,44:1065-1067.
[10] Gong B, Hu H, Chen J, et al. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells. Biomed Pharmacother, 2013,67:629-636.
[11] Sabile AA, Arlt MJ, Muff R, et al. Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice. Biochim Biophys Acta, 2013,1832:1173-1182. |
